Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Henan Puri Pharmaceutical Technology is a China-based pharmaceutical company specializing in the research, development, and manufacturing of high-end generic drugs and Active Pharmaceutical Ingredients (APIs). The company focuses on complex formulations and drug delivery technologies, including sustained-release and controlled-release systems. Their therapeutic portfolio primarily covers cardiovascular, respiratory, and anti-inflammatory diseases. Henan Puri operates state-of-the-art facilities that adhere to international GMP standards, providing CDMO services to global partners. By emphasizing quality and bioequivalence, the company aims to provide affordable alternatives to major branded medications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Henan Puri Pharmaceutical Technology.